Levels peak in your twenties and decline steadily after
It may be worth researching further if you: Are interested in senolytic approaches and want a peptide-based option rather than pharmaceutical senolytics (dasatinib + quercetin) Are focused on aging biology rather than acute performance or body composition goals Understand the evidence limitations and are comfortable with a compound that has strong preclinical data but zero human trials Have the budget FOXO4-DRI is one of the most expensive peptide protocols due to high per-kg dosing and costly D-amino acid synthesis FOXO4-DRI is not appropriate if you're looking for rapid, noticeable results or have a low risk tolerance for experimental compounds
Abstract A central process contributing to the phenotype of aging is cellular senescence
However, we found that the reactivity of phosphines with oxygen to form a phosphine oxide, along with the relatively long reaction times required and the instability of phosphine sulfides, decreased sensitivity
They show the copper-tripeptide class can be bioactive by injection in animals, but they are an analogy , not AHK-Cu proof
If this occured, it could under-report the levels of polysulfide sulfane sulfur, thus in our experiments we minimised incubation with TCEP without capping agent